Accure Acne Announces New FDA Clearance for the Long-Term Treatment of Acne

Accure Acne, Inc.(tm) (www.accureacne.com), a pioneer in the development of innovative solutions for the treatment of acne, announced today that it has received a new FDA Clearance K242035 for the long-term treatment of mild to severe inflammatory acne vulgaris. 

Read More